Literature DB >> 28797022

Evaluation of the Isoniazid Preventive Therapy Care Cascade Among HIV-Positive Female Sex Workers in Mombasa, Kenya.

Sylvia M LaCourse1, Ruth W Deya, Susan M Graham, Linnet N Masese, Walter Jaoko, Kischorchandra N Mandaliya, Julie Overbaugh, R Scott McClelland.   

Abstract

BACKGROUND: Kenyan female sex workers (FSWs) have a high HIV prevalence, increasing their tuberculosis (TB) risk. Despite recommendations that HIV-positive individuals be offered isoniazid preventive therapy (IPT), uptake has been limited.
METHODS: In this longitudinal cohort of HIV-positive FSWs, we retrospectively characterized the IPT care cascade between March 2000 and January 2010, including reasons for cascade loss or appropriate exit. Cascade success required completion of 6 months of IPT. Baseline characteristics were assessed as potential correlates of cascade loss using multivariable logistic regression.
RESULTS: Among 642 HIV-positive FSWs eligible for IPT evaluation, median age was 31 years (IQR 26-35) with median CD4 lymphocyte count of 409 (IQR 292-604) cells per cubic millimeter. There were 249 (39%) women who successfully completed 6 months of IPT, 157 (24%) appropriately exited the cascade, and 236 (37%) were cascade losses. Most cascade losses occurred at symptom screen (38%, 90/236), chest radiograph evaluation (28%, 66/236), or during IPT treatment (30%, 71/236). Twenty-nine women were diagnosed with tuberculosis, including one after IPT initiation. Most women initiating IPT completed the course (71%, 249/351); <5% had medication intolerance. Younger women [<25 and 25-35 vs. >35 years; adjusted odds ratio (AOR) 2.65, 95% confidence interval (CI): 1.46 to 4.80 and AOR 1.78, 95% CI: 1.13 to 2.80, respectively], and those evaluated for IPT after antiretroviral availability in 2004 (AOR 1.92, 95% CI: 1.31 to 2.81), were more likely to be cascade losses.
CONCLUSIONS: Implementation of IPT among HIV-positive FSWs in Kenya is feasible. However, significant losses along the IPT care cascade underscore the need for strategies improving retention in care.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28797022      PMCID: PMC5555166          DOI: 10.1097/QAI.0000000000001461

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  30 in total

1.  A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.

Authors:  Christine Danel; Raoul Moh; Delphine Gabillard; Anani Badje; Jérôme Le Carrou; Timothée Ouassa; Eric Ouattara; Amani Anzian; Jean-Baptiste Ntakpé; Albert Minga; Gérard M Kouame; Franck Bouhoussou; Arlette Emieme; Antoine Kouamé; André Inwoley; Thomas-d'Aquin Toni; Hugues Ahiboh; Mathieu Kabran; Cyprien Rabe; Baba Sidibé; Gustave Nzunetu; Romuald Konan; Joachim Gnokoro; Patrice Gouesse; Eugène Messou; Lambert Dohoun; Synali Kamagate; Abo Yao; Solange Amon; Amadou-Barenson Kouame; Aboli Koua; Emmanuel Kouamé; Yao Ndri; Olivier Ba-Gomis; Marcelle Daligou; Simplice Ackoundzé; Denise Hawerlander; Alex Ani; Fassery Dembélé; Fatoumata Koné; Calixte Guéhi; Constance Kanga; Serge Koule; Jonas Séri; Mykayila Oyebi; Nathalie Mbakop; Olewole Makaila; Carole Babatunde; Nathanael Babatounde; Gisèle Bleoué; Mireille Tchoutedjem; Alain-Claude Kouadio; Ghislaine Sena; Sahinou-Yediga Yededji; Rodrigue Assi; Alima Bakayoko; Alassane Mahassadi; Alain Attia; Armel Oussou; Max Mobio; Doféré Bamba; Mesmin Koman; Apollinaire Horo; Nina Deschamps; Henri Chenal; Madeleine Sassan-Morokro; Seidou Konate; Kakou Aka; Eba Aoussi; Valérie Journot; Célestin Nchot; Sophie Karcher; Marie-Laure Chaix; Christine Rouzioux; Papa-Salif Sow; Christian Perronne; Pierre-Marie Girard; Hervé Menan; Emmanuel Bissagnene; Auguste Kadio; Virginie Ettiegne-Traore; Corinne Moh-Semdé; Abo Kouame; Jean-Marie Massumbuko; Geneviève Chêne; Mireille Dosso; Serge K Domoua; Thérèse N'Dri-Yoman; Roger Salamon; Serge P Eholié; Xavier Anglaret
Journal:  N Engl J Med       Date:  2015-07-20       Impact factor: 91.245

Review 2.  Use of isoniazid preventive therapy for tuberculosis prophylaxis among people living with HIV/AIDS: a review of the literature.

Authors:  Melissa A Briggs; Courtney Emerson; Surbhi Modi; Nicholas Kenji Taylor; Anand Date
Journal:  J Acquir Immune Defic Syndr       Date:  2015-04-15       Impact factor: 3.731

Review 3.  The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis.

Authors:  Hannah Alsdurf; Philip C Hill; Alberto Matteelli; Haileyesus Getahun; Dick Menzies
Journal:  Lancet Infect Dis       Date:  2016-08-10       Impact factor: 25.071

Review 4.  Treatment of latent tuberculosis infection in HIV infected persons.

Authors:  Christopher Akolo; Ifedayo Adetifa; Sasha Shepperd; Jimmy Volmink
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

5.  A 15-year study of the impact of community antiretroviral therapy coverage on HIV incidence in Kenyan female sex workers.

Authors:  R Scott McClelland; Barbra A Richardson; Peter Cherutich; Kishorchandra Mandaliya; Grace John-Stewart; Benard Miregwa; Katherine Odem-Davis; Walter Jaoko; Davies Kimanga; Julie Overbaugh
Journal:  AIDS       Date:  2015-11       Impact factor: 4.177

Review 6.  Adherence to antiretroviral therapy in adolescents living with HIV: systematic review and meta-analysis.

Authors:  Sung-Hee Kim; Sarah M Gerver; Sarah Fidler; Helen Ward
Journal:  AIDS       Date:  2014-08-24       Impact factor: 4.177

Review 7.  Antiretroviral therapy uptake, attrition, adherence and outcomes among HIV-infected female sex workers: a systematic review and meta-analysis.

Authors:  Elisa Mountain; Sharmistha Mishra; Peter Vickerman; Michael Pickles; Charles Gilks; Marie-Claude Boily
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

Review 8.  Incidence of HIV-associated tuberculosis among individuals taking combination antiretroviral therapy: a systematic review and meta-analysis.

Authors:  Tendesayi Kufa; Tonderai Mabuto; Evans Muchiri; Salome Charalambous; Dominique Rosillon; Gavin Churchyard; Rebecca C Harris
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

Review 9.  Interventions to improve delivery of isoniazid preventive therapy: an overview of systematic reviews.

Authors:  Lisa V Adams; Elizabeth A Talbot; Karen Odato; Heather Blunt; Karen R Steingart
Journal:  BMC Infect Dis       Date:  2014-05-21       Impact factor: 3.090

Review 10.  The HIV treatment cascade and care continuum: updates, goals, and recommendations for the future.

Authors:  Emma Sophia Kay; D Scott Batey; Michael J Mugavero
Journal:  AIDS Res Ther       Date:  2016-11-08       Impact factor: 2.250

View more
  5 in total

1.  Determinants of isoniazid preventive therapy completion among people living with HIV attending care and treatment clinics from 2013 to 2017 in Dar es Salaam Region, Tanzania. A cross-sectional analytical study.

Authors:  Masanja Robert; Jim Todd; Bernard J Ngowi; Sia E Msuya; Angella Ramadhani; Veryhel Sambu; Isaya Jerry; Martin R Mujuni; Michael J Mahande; James S Ngocho; Werner Maokola
Journal:  BMC Infect Dis       Date:  2020-04-10       Impact factor: 3.090

2.  Outcomes of isoniazid preventive therapy among people living with HIV in Kenya: A retrospective study of routine health care data.

Authors:  Muthoni Karanja; Leonard Kingwara; Philip Owiti; Elvis Kirui; Faith Ngari; Richard Kiplimo; Maurice Maina; Enos Masini; Elizabeth Onyango; Catherine Ngugi
Journal:  PLoS One       Date:  2020-12-02       Impact factor: 3.240

3.  Early-phase scale-up of isoniazid preventive therapy for people living with HIV in two districts in Malawi (2017).

Authors:  Scott A Nabity; Laurence J Gunde; Diya Surie; Ray W Shiraishi; Hannah L Kirking; Alice Maida; Andrew F Auld; Michael Odo; Andreas Jahn; Rose K Nyirenda; John E Oeltmann
Journal:  PLoS One       Date:  2021-04-01       Impact factor: 3.240

4.  Drop-offs in the isoniazid preventive therapy cascade among children living with HIV in western Kenya, 2015-2019.

Authors:  Dickens Otieno Onyango; Marianne A B van der Sande; Courtney M Yuen; Jerphason Mecha; Daniel Matemo; Elizabeth Oele; John Kinuthia; Grace John-Stewart; Sylvia M LaCourse
Journal:  J Int AIDS Soc       Date:  2022-08       Impact factor: 6.707

5.  Intentional abortion and its associated factors among female sex workers in Iran: Results from national bio-behavioral surveillance-2020.

Authors:  Ghobad Moradi; Mohammad Mehdi Gouya; Elnaz Ezzati Amini; Sahar Sotoodeh Ghorbani; Samaneh Akbarpour; Bushra Zareie; Neda Izadi; Farzaneh Kashefi; Yousef Moradi
Journal:  PLoS One       Date:  2022-08-29       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.